Similar companies
Income Statement (USD)
| Q1 '24 | QoQ | |
|---|---|---|
| Revenue | 1.02B | 0.5% |
| Gross Profit | 542M | 4.4% |
| Cost of Revenue | 476M | 6.7% |
| Operating expense | 332M | 10.1% |
| Net Income | 170M | 31.1% |
| EBITDA | 250M | 8.2% |
Balance Sheet (USD)
| Q1 '24 | QoQ | |
|---|---|---|
| Total Assets | 8.71B | 2.9% |
| Total Liabilities | 3.87B | 1.4% |
| Total Equity | 4.84B | 4.1% |
| Shares Outstanding | 236M | 1.1% |
Cash Flow (USD)
| Q1 '24 | QoQ | |
|---|---|---|
| Cash from operations | 292M | 32.9% |
| Cash from investing | -39M | 63.1% |
| Cash from financing | -4.2M | 99.6% |
EPS
Financial Highlights for Hologic in Q1 '24
Hologic reported a revenue of 1.02B, which is a 0.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 542M, marking a -4.4% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 476M, a 6.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 332M, showing a -10.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 170M, showing a -31.1% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 250M, showing a 8.2% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Hologic faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
